News

Project title:Developing a portable diagnostic device based on lab-on-chip analysis system to detect COVID-19 disease (SARS-CoV-2 pathogen). ...

Genomtec S.A. has launched an initial public offering of up to 730,000 J-series shares. The maximum price per share was agreed at PLN 11. The ...

Work on the mobile diagnostic platform – Genomtec ID, began in 2017 and currently we are starting its industrialization, proudly presenting ...

Due to the dynamic growth in space the of company’s flagship project – Genomtec ID, the Management Board, fulfilling expectations of its ...

We would like to kindly inform you on our plans to adjust Company’s organizational structure to comply with all the conditional regulatory ...

Genomtec® SARS-CoV-2 RT-LAMP/N CE-IVD laboratory kit is our first product in the SARS-CoV-2 pipeline. After just over 10 weeks of hard work we ...